SCHEMBL7309630

SCHEMBL7309630

CC(C)C[C@H](C)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1494096 1.00
SCHEMBL18103118 1.00
Hydrochloric Acid SCHEMBL7781988 0.97
Ammonia Solution, Strong SCHEMBL9538657 0.97
SCHEMBL18897588 0.94 ALDH1A1 (0.40)
SCHEMBL2486901 0.85
SCHEMBL23340759 0.84 ALDH1A1 (0.38)
SCHEMBL11332093 0.81 ALDH1A1 (0.44)
SCHEMBL22004592 0.80 CACNA2D1 (0.37)
SCHEMBL12793762 0.78 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697804-B2 Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy THE JOHNS HOPKINS UNIVERSITY (US) 2023-07-11 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-0236872-A2 Hydroxyl amine derivatives, their preparation and use as medicaments F. HOFFMANN-LA ROCHE AG (CH) 1987-09-16 EP disclosed